Anebulo Pharmaceuticals Inc (ANEB)
1.84
-0.04
(-2.13%)
USD |
NASDAQ |
Nov 01, 16:00
Anebulo Pharmaceuticals Total Liabilities (Quarterly): 0.2606M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.2606M |
| March 31, 2024 | 1.010M |
| December 31, 2023 | 1.014M |
| September 30, 2023 | 0.7166M |
| June 30, 2023 | 1.069M |
| March 31, 2023 | 1.491M |
| December 31, 2022 | 1.372M |
| September 30, 2022 | 0.6982M |
| Date | Value |
|---|---|
| June 30, 2022 | 0.5125M |
| March 31, 2022 | 0.0858M |
| December 31, 2021 | 0.0499M |
| September 30, 2021 | 0.6077M |
| June 30, 2021 | 0.2416M |
| March 31, 2021 | 13.73M |
| December 31, 2020 | 3.330M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.0499M
Minimum
Dec 2021
13.73M
Maximum
Mar 2021
1.746M
Average
0.7166M
Median
Sep 2023
Total Liabilities (Quarterly) Benchmarks
| Revance Therapeutics Inc | 624.54M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Palatin Technologies Inc | 10.85M |
| iBio Inc | 7.41M |
| Theriva Biologics Inc | 14.74M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.073M |
| Shareholders Equity (Quarterly) | 3.812M |